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Abstract
Obesity induces white adipose tissue (WAT) dysfunction characterized by unremitting
inflammation and fibrosis, impaired adaptive thermogenesis and increased lipolysis. Prosta-
glandins (PGs) are powerful lipid mediators that influence the homeostasis of several
organs and tissues. The aim of the current study was to explore the regulatory actions
of PGs in human omental WAT collected from obese patients undergoing laparoscopic bar-
iatric surgery. In addition to adipocyte hypertrophy, obese WAT showed remarkable inflam-
mation and total and pericellular fibrosis. In this tissue, a unique molecular signature
characterized by altered expression of genes involved in inflammation, fibrosis and WAT
browning was identified by microarray analysis. Targeted LC-MS/MS lipidomic analysis
identified increased PGE2 levels in obese fat in the context of a remarkable COX-2 induction
and in the absence of changes in the expression of terminal prostaglandin E synthases (i.e.
mPGES-1, mPGES-2 and cPGES). IPA analysis established PGE2 as a common top regu-
lator of the fibrogenic/inflammatory process present in this tissue. Exogenous addition of
PGE2 significantly reduced the expression of fibrogenic genes in humanWAT explants and
significantly down-regulated Col1α1, Col1α2 and αSMA in differentiated 3T3 adipocytes
exposed to TGF-β. In addition, PGE2 inhibited the expression of inflammatory genes (i.e. IL-
6 and MCP-1) in WAT explants as well as in adipocytes challenged with LPS. PGE2 anti-
inflammatory actions were confirmed by microarray analysis of human pre-adipocytes incu-
bated with this prostanoid. Moreover, PGE2 induced expression of brown markers (UCP1
and PRDM16) in WAT and adipocytes, but not in pre-adipocytes, suggesting that PGE2
might induce the trans-differentiation of adipocytes towards beige/brite cells. Finally,
PGE2 inhibited isoproterenol-induced adipocyte lipolysis. Taken together, these findings
identify PGE2 as a regulator of the complex network of interactions driving uncontrolled
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Introduction
Prostaglandin (PG) E2 is one of the most abundant lipid mediators in the human body. It is
constitutively produced in nearly all tissues by the coordinate enzymatic activities of cyclooxy-
genases (COX) and terminal PGE synthases [1–4]. PGE2 is a powerful molecule that exerts
multiple biological effects depending on the tissue environment and the cell type [1–4]. In this
regard, in addition to being recognized as an important mediator of inflammation, pain and
fever, PGE2 also plays an important role in the regulation of vascular tone and cell proliferation
and differentiation [5–7].
White adipose tissue (WAT) is a complex and highly active endocrine organ that plays a
key role in the regulation of energy metabolism. In obese individuals, WAT expands its
energy-buffering capacity by fat cell hypertrophy and/or by hyperplasia from committed pro-
genitors [8]. This adipose tissue expansion leads to a plethora of functional derangements
including hypoxia, lack of nutrients and tissue remodeling, which are major contributors to the
chronic “low-grade” state of mild inflammation present in WAT of obese individuals [9–11].
This persistent and unresolved inflammatory state in WAT is, in turn, responsible for the
excessive synthesis of extracellular matrix components and the subsequent interstitial deposi-
tion of fibrotic material [12,13]. Increased interstitial WAT fibrosis decreases extracellular
matrix flexibility and reduces the tissue plasticity, which ultimately leads to adipocyte dysfunc-
tion [12]. The ultimate consequence of these derangements is the development of a number of
comorbidities associated with obesity including insulin resistance and type 2 diabetes, non-
alcoholic fatty liver disease, atherosclerosis and cardiovascular disease [14,15].
We recently described that PGE2 participates in the differentiation of WAT pre-adipocytes
into beige/brite cells [16]. Since beige/brite cells are able to dissipate large amounts of chemical
energy as heat by uncoupling protein 1 (UCP1), which uncouples the synthesis of ATP from
the respiratory chain [17], this finding was interpreted as favorable within the context of meta-
bolic homeostasis of obese WAT. The aim of the current study was to translate and expand this
finding to human obesity by investigating the potential metabolic benefits of PGE2 in WAT
remodelling, inflammation, adaptive thermogenesis and lipolysis in omental adipose tissue
obtained from obese individuals undergoing bariatric surgery. Our data provide evidence
that PGE2 exerts pleiotropic regulatory effects in the complex homeostasis of WAT in human
obesity.
Materials and Methods
Reagents
PGE2 was obtained from Cayman Chemicals (Ann Arbor, MI). Krebs-Ringer bicarbonate
buffer, Dulbecco's Modified Eagle's Medium (DMEM), fatty acid-free (FAF)-BSA and liberase
were from Roche (Basel, Switzerland). Nylon mesh filters (100 μm) were obtained from BD
Biosciences (San Jose, CA). TRIzol was from Invitrogen (Carlsbad, CA) and L-Glutamine from
Biological Industries (Kibbutz Beit Haemek, Israel). FBS and Dulbecco’s PBS with and without
calcium and magnesium (DPBS+/+ and DPBS-/-, respectively) were obtained from Lonza (Ver-
vieres, Belgium). The free glycerol assay kit was from Sigma (St. Louis, MO). The High-Capac-
ity Archive Kit and TaqMan Gene Expression Assays were provided by Applied Biosystems
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(Foster City, CA). Adipocyte maintenance medium was from Zen Bio (Research Triangle Park,
NC). The Pierce BCA Protein Assay kit was from Thermo Scientific (Carlsbad, CA).
Study participants and sample collection
Twelve obese individuals undergoing laparoscopic bariatric surgery and 10 patients without a
history of obesity undergoing laparoscopic cholecystectomy were recruited at the Gastroenter-
ology Surgery Unit of the Hospital Clínic of Barcelona. The participants were selected accord-
ing to their body mass index (BMI) calculated as mass/height2 and categorized as non-obese
control (BMI<29.9 kg/m2) and obese (BMI>29.9 kg/m2) groups. Individuals with the presence
of inflammatory bowel disease or cancer, obese patients with previous bariatric surgical proce-
dures or patients with active prescription for any non-steroidal anti-inflammatory drug
(NSAID) or any other medication that could affect PG synthesis were excluded from the study.
Demographic and clinical data were collected from the electronic medical records of the
patients at the time of surgery. Omental adipose tissue samples were harvested and washed
twice with DPBS and minced into approximately 100 mg pieces. Tissue samples were either
fixed in 10% formalin or snap-frozen in liquid nitrogen and stored at -80°C for further analysis.
Some adipose tissue samples were used ex vivo or for the isolation of primary adipocytes and
pre-adipocytes. This study was approved by the Investigation and Ethics Committee of the
Hospital Clínic and written informed consent was obtained from all the participants (protocol
# 12–7239).
Assessment of adipose tissue fibrosis by Sirius Red and Masson’s
trichrome staining
Fibrosis in adipose tissue was assessed in paraffin sections by Sirius Red staining. Briefly, sec-
tions were incubated for 10 minutes in 0.5% thiosemicarbazide and stained in 0.1% Sirius Red
F3B in saturated picric acid for 1 hour, and subsequently washed with an acetic acid solution
(0.5%). Fibrosis was also assessed by Masson’s trichrome staining at the Pathology Department
of the Hospital Clínic.
Assessment of adipose tissue fibrosis by bright field and polarization
microscopy
Sections of visceral adipose tissue stained with picrosirius red were visualized in a DMRB-Leica
microscope (Wetzlard, Germany), equipped with a wide-field Leica DFC 450 camera and a λ
analyzer and polarizer. Acquisition of the images was performed with the LAS 4.0 Leica soft-
ware at 20xPL FLUOTAR Dry Numerical Aperture 0.50 and 40X PL FLUOTAR 1–0.5 oil. The
same region of the sample was imaged using bright field to visualize picrosirius stained tissue
and polarized light to observe collagen fibbers. Image analysis was performed using FIJI-Image
J (Wayne Rasband, NIH). Briefly, images of bright field and polarized light were background
subtracted, filtered and automatically thresholded to segment and quantify areas of cellular
membrane in bright field images and areas of fibrotic regions visualized under polarized light.
Total fibrosis quantification (sum of collagen I and III fibers) was expressed as the ratio of
fibrous regions/cellular membranes as described in reference 13. The same procedure was used
for quantification of pericellular fibrosis.
Ex vivo experiments in adipose tissue explants
HumanWAT explants collected under sterile conditions were placed in P60 plates in pre-warmed
(37°C) DPBS+/+ containing antibiotics (100 U/ml penicillin and 100 mg/ml streptomycin).
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Connective tissue and blood vessels were removed by dissection before cutting the tissue into
small pieces. The explants were washed with DPBS at 37°C by centrifugation (400g, 1 min) to
remove blood cells and pieces of tissue containing insufficient adipocytes to float. Thereafter, the
explants were cultured in DMEMwith L-glutamine (2 mM), antibiotics and 10% FAF-BSA. Tis-
sue explants of approximately 40 mg were subsequently cultured in 12-well plates with vehicle
(0.4% ethanol) or PGE2 (1 μM) in 1% FAF-BSA for 24 h.
Isolation of adipocytes and pre-adipocytes
WAT was excised, weighed and rinsed twice in cold carbogen-gassed Krebs-Ringer bicarbonate
buffer supplemented with 1.5% FAF-BSA and 2 mM EDTA and centrifuged at 800g for 1 min
at 4°C to remove free erythrocytes and leukocytes. Tissue suspensions (300–600 mg) were
placed in 5 ml of digestion buffer containing Krebs-Ringer supplemented with 1.5% FAF-BSA
and 1 mg/ml of liberase and incubated at 37°C for 30 min as described [18]. Floating cells cor-
responding to adipocytes were collected and cultured in DMEM with FBS (10%), L-glutamine
(2 mM), antibiotics and HEPES (20 mM). The remaining supernatant was centrifuged at 800g
for 5 min and pelleted cells corresponding to the stromal vascular cell (SVC) fraction were
incubated with erythrocyte lysis buffer (0.15 M NH4Cl, 10 mM KHCO3, and 0.1 mM EDTA)
for 5 min and centrifuged at 500g for 5 min, as described (16). Thereafter, SVC were incubated
in a culture flask containing pre-adipocyte priming DMEM/F-12/Ham’s mediun with L-gluta-
mine, HEPES, 10% FBS and antibiotics for 24 hours.
Pre-adipocyte differentiation into beige/brite cells
Freshly isolated WAT pre-adipocytes were cultured in DMEM containing 3% FBS, 100 nM
insulin and antibiotics and incubated with vehicle (0.01% ethanol) or PGE2 (0.1 μM) for 3
hours. The induction medium was replaced with fresh adipocyte maintenance medium
(33 μM biotin, 17 μM pantothenate, 1 μM dexamethasone) in the presence of 1 nM triiodothy-
ronine (T3) for 2 additional days. Thereafter, the cells were incubated in adipocyte medium
until day 10.
Differentiation of 3T3-L1 adipocytes
Mouse 3T3-L1 cells were seeded onto 24-well plates (75.000 cells/well) with DMEM supple-
mented with 10% FBS and maintained in a 5% CO2 atmosphere. Cells were allowed to grow to
confluence for 2 days and then exposed to DMEM containing a differentiation cocktail (5 μg/
ml insulin, 0.25 μM dexamethasone and 0.5 mM IBMX) supplemented with antibiotics and 2
mM L-glutamine in the presence of vehicle (0.01% DMSO), PGE2 (0.1, 1 and 5 μM) or com-
pound III (1, 5 and 8 μM). After 48 h, the cells were grown in fresh DMEM with 10% FBS and
5 μg/ml insulin. Finally, the medium was replaced by fresh DMEM after 48h. Six days later, the
cells were incubated with vehicle or LPS (100 ng/ml) for 6 h. In some experiments cells were
allowed to grow to confluence for 2 days and then incubated in DMEM containing a differenti-
ation cocktail in the presence of vehicle (0.01% DMSO), TGF-β (10 ng/ml) and PGE2 (0.1, 1
and 5 μM). After 48 h, the cells were grown in fresh DMEM with 10% FBS and 5 μg/ml insulin.
Finally, the medium was replaced by fresh DMEM after 48 h.
High-throughput transcriptomic analysis
Total RNA was obtained from omental WAT collected from obese patients (n = 4) and non-
obese individuals (n = 4). RNA was also obtained from primary cultures of human pre-adipo-
cytes (n = 8) incubated in the absence or presence of PGE2 (1 μM) for 3 h. Affymetrix Human
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Genome U219 expression arrays containing more than 36,000 transcripts and variants (Affy-
metrix, Inc., Santa Clara, CA) were used to process all the samples. The preparation of cRNA
probes, hybridization, and scanning of arrays were performed according to the manufacturer’s
protocol and carried out at the Functional Genomics Unit of IDIBAPS. Affymetrix gene
expression data were normalized with the robust multiarray algorithm using a custom probe
set definition that mapped probes directly to Entrez Gene Ids (HGU219_Hs_ENTREZG). A
filtering step excluding probes not reaching a coefficient of variation of 0.02 was employed,
and the final number of probes reached a total of 13,928 probes. For the detection of differen-
tially expressed genes, a linear model was fitted to the data and empirical Bayes moderated sta-
tistics were calculated using the Limma package from Bioconductor (Seattle, WA). Adjustment
of p-values was made by the determination of false discovery rates (FDR) using the Benjamini-
Hochberg procedure [19]. All computations were made using R statistical software. Genes rep-
resenting a fold change of 1.5 or greater and a moderate p-value<0.05 were considered as dif-
ferentially expressed. The array data were analyzed using the IPA Analysis software. The
significance of the association between the data set and the canonical pathway was determined
based on a P value calculated using the Fischer's exact test determining the probability that the
association between the genes in the data set and the canonical pathway is due to chance alone.
The microarray data have been deposited in Gene Expression Omnibus (GEO): GSE7141.
Lipidomic analysis of eicosanoids by LC-ESI-MS/MS
COX-derived products were measured in adipose tissue samples (30 mg) from obese and non-
obese subjects by targeted LC-ESI-MS/MS analysis. Samples were extracted using solid phase
extraction columns and the hexane elute was evaporated before injection into an Agilent 1200
HPLC system with a binary pump, degasser, autosampler and column thermostat with a Kine-
tex C-18, 2.1 x 150 mm, 2.6 μm (Phenomenex, Aschaffenburg, Germany) column using a sol-
vent system of aqueous formic acid (0.1%) and acetonitrile. The elution gradient was started
with 5% acetonitrile, which was increased to 55% within 0.5 minutes, to 69% in 14.5 minutes,
and 95% in 14.6 minutes where it was maintained for 5.4 minutes. The flow rate was set at 0.3
mL/min and the injection volume was 7.5 μL. The HPLC was coupled with an Agilent 6460
Triplequad mass spectrometer (Agilent Technologies, Santa Clara, CA) with an electrospray
ionisation source. The source parameters were: drying gas: 250°C/10 L/min, sheath gas: 400°C/
10 L/min, capillary voltage: 4500 V, nozzel voltage: 1500 V and nebulizer pressure: 30 psi. The
LC-MS/MS conditions are given in S1 Table.
Lipolysis assay
Human adipocytes were harvested and incubated in DMEM containing 10% FBS in the pres-
ence or absence of isoproterenol (1 μM) and PGE2 (1 μM) for 1.5–3 h at 37°C. Glycerol release
into the media was determined using a free-glycerol assay kit. Glycerol levels were normalized
to the total protein content of the primary adipocytes using the BCA protein assay kit.
Analysis of gene expression by real-time PCR
Total RNA was isolated using the TRIzol reagent and concentration was assessed in a Nano-
Drop-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). RNA integrity was
tested with a RNA 6000 Nano Assay in a Bioanalyzer 2100 (Agilent Technologies, Santa Clara,
CA). cDNA synthesis of 0.5–1 μg of total RNA was performed using the High-Capacity cDNA
Archive Kit (Applied Biosystems). Quantitative analysis of gene expression was performed by
real-time PCR in an ABI Prism 7900 Sequence Detection System in Fast Real Time System. We
carried out real-time PCR using optimal and pre-designed TaqMan Gene Expression Assays
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(COX-2 (Hs00153133_m1 and Mm00478374_m1), mPGES-1 (Hs 01115610_m1), mPGES-
2 (Hs00228159_m1), cPGES (Hs00832847_gH)), UCP1 (Hs00367969_m1), PRDM16
(Hs00922674_m1), Col1α1 (Hs00164004 andMm00801666_g1), Col1α2 (Hs01028969_m1 and
Mm00483888_m1), TGF-β (Hs00998133_m1 and Mm03023971_m1), TIMP-1 (Hs00171558
and Mm01341361_m1), αSMA (Hs00559403_m1 andMm00725412_s1), IL-6 (Hs00174122_m1
and Mm00446190_m1) andMCP-1 (Hs00234140_m1 and Mm00441242_m1). β-actin
(Hs00969077_m1 and Mm00607939_s1) was used as endogenous control. PCR results were ana-
lyzed with the Sequence Detector Software version 2.1 (Applied Biosystems). Relative quantifica-
tion of gene expression was performed using the comparative Ct method. The amount of target
gene normalized to β-actin and relative to a calibrator was determined by the arithmetic equation
2-ΔΔCt described in the comparative Ct method.
Analysis of protein expression by western blot
Tissue samples were homogenized with 50 mMHEPES, 20 mM β-glycerol phosphate, 2 mM
EDTA, 1% Igepal, 10% glycerol, 1 mMMgCl2, 1 mM CaCl2 and 150 mMNaCl, supplemented
with protease inhibitor (Complete Mini) and phosphatase inhibitor (PhosSTOP) cocktails
(Roche, Basel, Switzerland). A total of 60 μg protein per tissue were resuspended in SDS-con-
taining Laemmli sample buffer, heated for 5 min at 95°C, and resolved in 15% SDS-PAGE. The
transfer was performed in the iBlot Dry Blotting System (Invitrogen) at 20 V for 7 min. The
transfer was visualized by Ponceau S solution. Membranes were then soaked for 1 h at room
temperature in TBS (20 mM Tris/HCL pH 7.4 and 0.5 M NaCl) containing 0.1% (v/v) Tween
20 (0.1% TBST) and 5% (w/v) non-fat dry milk. The blots were washed three times for 5 min
each with 0.1% TBST and subsequently incubated overnight at 4°C with primary anti-phos-
pho-HSL (dilution 1:1000) and anti-total-HSL (dilution 1:1000) (Cell Signaling, Danvers, MA)
antibodies in 0.1% TBST containing 5% BSA. After washing the blots three times for 5 min
each with 0.1% TBST, the membranes were incubated for 1 hour at room temperature with an
HRP-linked donkey anti-rabbit secondary (dilution 1:2000) antibody (Biolegend, San Diego,
CA) in 0.1% TBS-T. Bands were visualized using the EZ-ECL chemiluminescence detection Kit
(Biological Industries) in a LAS 4000 imaging system (GE Healthcare Life Sciences, San Fran-
cisco, CA) and quantified using Image GE ImageQuant TL analysis software.
Statistical analysis
Statistical significance for the inferred association between target RNAs and biological path-
ways/processes was assessed by the Fisher’s z-score a measure of the likelihood that the associa-
tion between a set of genes and a given pathway is not due to random chance. For comparison
of 3 groups or conditions, ANOVA was used. For other statistical analysis the Student’s t-test
was used. Differences between lean and obese subjects were adjusted for age using univariate
analysis based on a linear regression model. The results are expressed as mean ± SEM, and dif-
ferences were considered significant at P< 0.05. The results are expressed as mean ± SEM, and
differences were considered significant at P< 0.05.
Results
Patient characteristics and assessment of adipose tissue fibrosis
The demographic and clinical characteristics of the patients included in the study are shown in
S2 Table. Obese individuals were younger and had a greater body weight and body mass index
(BMI) compared to non-obese individuals. There were no statistically significant differences in
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serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), glucose, cholesterol
and triglyceride (TAG) levels between the two study cohorts.
Histological analysis of WAT sections revealed that in addition to increased adipocyte
hypertrophy, obesity was associated with abnormal collagen deposition. Indeed, Sirius Red and
Masson’s trichrome staining, which specifically stain collagen fibers, were increased in omental
WAT from obese patients as compared to that from non-obese controls (Fig 1A). Total as well
as pericellular fibrosis were analyzed by visualization of collagen fibers (red, type I collagen;
green, type III collagen) under polarized light microscopy (Fig 1B). Quantification of total
fibrosis (sum of collagen I and III fibers) and pericellular fibrosis is shown in Fig 1C. A statisti-
cally significant up-regulation of the fibrosis marker TIMP1 was also seen in WAT from obese
individuals, whereas changes in collagen type I alpha 1 (Col1α1), α-smooth muscle actin
(αSMA) and TGF-β expression did not reach statistical significance (Fig 1D and 1E). In parallel
to exacerbated fibrosis, obese WAT showed significant up-regulation of the inflammatory
genes interleukin (IL)-6 and the macrophage marker CD68 (Fig 1F).
High-throughput analysis of gene expression in adipose tissue
In order to investigate changes in the profile of gene expression, we performed high-throughput
transcriptome analysis in omental WAT from obese and non-obese individuals. This analysis
identified a group of genes associated with the inflammation-fibrosis axis that was differentially
modulated in obesity (Fig 2A). Among the genes involved in fibrosis, we identified changes in
members of the collagen synthesis (COL6A6 and COL1A1), metalloproteases (MMP9 and
MMP19), tissue inhibitors of metalloproteases (TIMP1) and TGF-β signaling cascade (TGFB1
and SMAD1) and αSMA (ACTA2) (Fig 2A). Among the inflammatory genes, we found signifi-
cant up-regulation of members of the cyclooxygenase (COX) and lipoxygenase (LOX) pathways
(PTGS2 (COX-2), PTGER4 (PGE2 receptor 4) and ALOX5 (5-LOX)); integrins (ITGAM and
ITGB2); cytokines (IL20 and IL15) as well as IL-6, IL-1β and IL-10 (not shown in the heat-
map); chemokines (i.e. CXCL1 (GROα), CXCR1, and CXCR2 (IL-8 receptors)) as well as MCP-
1 (not shown in the heat-map) and CD68. Over-expression of the inflammatory adipokines
resistin and leptin was also seen (data not shown). On the other hand, the transcriptome analy-
sis identified the up-regulation of genes involved in adipogenesis (CEBPB) and a significant
down-regulation of a cluster of genes involved in WAT browning (i.e. PRDM4, PDRM9,
PDRM10 and PPARGC1A). By means of functional Ingenuity Pathway Analysis (IPA), we con-
firmed the presence of a strong association between changes in genes involved in inflammation
and fibrosis inWAT from obese patients (Fig 2B). Moreover, IPA analysis identified a number
of pathways related to inflammation and fibrosis as the top canonical pathways differentially
regulated inWAT from obese patients (S3 Table). Finally, IPA analysis identified PGE2 as a
common top regulator of the inflammatory and fibrogenic processes in obese WAT (Fig 2C).
Assessment of PG levels by LC-ESI-MS/MS
We next assessed PG levels in omental WAT from obese and non-obese individuals by targeted
lipidomic LC-ESI-MS/MS analysis. As shown in Fig 3A, significantly higher levels of PGE2 and
6-keto-PGF1α, the inactive PGI2 metabolite, were detected in obese WAT compared to samples
from non-obese controls. In contrast, PGF2α was significantly reduced in obese adipose tissue
(Fig 3A). Levels of PGD2 (data not shown) and its adipogenic metabolite, 15d-PGJ2 (Fig 3A)
were not different between the two groups. TXB2, PGJ2 and PGH2 levels were undetectable
(data not shown). Increased PGE2 levels occurred in the context of increased COX-2 expres-
sion without changes in the terminal prostaglandin E synthases (i.e. mPGES-1, mPGES-2 and
cPGES) (Fig 3B). Absence of changes in the expression of mPGES-1 was confirmed at the
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protein level by western blot analysis (Fig 3C). This finding is consistent with the down-regula-
tion of mPGES-1 in adipose tissue from high-fat diet induced obese mice [20]. Interestingly,
the expression of COX-2, but not mPGES-1, increased in a BMI-dependent manner and closely
correlated with the degree of obesity (Fig 3D).
Effects of PGE2 onWAT fibrosis
We then evaluated the effects of PGE2 on the fibrotic process in WAT explants from obese
individuals. As shown in Fig 4A, incubation of fat explants with PGE2 significantly reduced the
Fig 1. Increased fibrosis and inflammation in obese adipose tissue. (A) Representative photomicrographs (×200 magnification; scale bars: 200 μm) of
omental white adipose tissue (WAT) sections stained with Sirius Red and Masson’n trichrome from non-obese control individuals (n = 8) and obese patients
(n = 8). (B) Representative photomicrographs (×200 and x400 magnifications; scale bars: 100 μm) of obeseWAT sections stained with Picrosirius Red (left
panels) and visualized under polarized light (right panels). Arrows indicate accumulation of fibrosis around adipocytes. (C) Total and pericellular fibrosis
expressed as percentage of the total cellular membranes in omental WAT from control and obese individuals. (D,E)mRNA expression for COLα1, TIMP1,
αSMA and TGF-β in WAT from control and obese individuals. (F)mRNA expression of inflammatory markers IL-6 and CD68 in WAT. Results are expressed
as mean ± SEM. *, P<0.01 and **, P<0.005 versus control.
doi:10.1371/journal.pone.0153751.g001
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expression of the fibrogenic genes Col1α1 and Col1α2 (Fig 4A). Changes in TIMP1 and TGF-β
did not reach statistical significance (Fig 4A). Expression of αSMA was not detected in un-
stimulated adipose tissue explants (data not shown). To further investigate the effects of PGE2
on adipose tissue remodeling, we performed in vitro experiments in mature adipocytes. Since
the surgical pieces of fat collected in the surgical room yielded an insufficient number of pre-
adipocytes, the in vitro experiments were performed in adipocyte-differentiated 3T3-L1 cells,
which allowed us enough biological material for performing extensive in vitro studies. As
shown in Fig 4B, 3T3 adipocytes growing in the presence of the pro-fibrogenic cytokine TGF-β
showed a significant up-regulation in Col1α1, TIMP1, Col1α2, TGF-β and αSMA. Under
TGF-β stimulation PGE2 produced a significant down-regulation of the fibrogenic genes
Col1α1, Col1α2, TGF-β and αSMA (Fig 4C).
Fig 2. High-throughput transcriptomic analysis of adipose tissue from control and obese individuals. (A) Differential gene expression by Affymetrix
Human Genome U219 expression arrays in omental adipose tissue from non-obese control individuals (n = 4) and obese patients (n = 4). The results are
expressed as a matrix view of gene expression data (heat map) in which rows represent genes and columns represent hybridized samples. The intensity of
each colour denotes the standardized ratio between each value and the average expression of each gene across all samples. Red pixels correspond to an
increased abundance of mRNA in the samples indicated, whereas green pixels indicate decreased mRNA levels. (B) Integrative IPA of transcriptomic data.
Genes significantly down-regulated are indicated in green; those that were significantly up-regulated are indicated in red. (C) Cascade of top regulators of
inflammation and fibrosis detected by IPA software.
doi:10.1371/journal.pone.0153751.g002
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Effects of PGE2 onWAT inflammation
We also studied the effects of PGE2 on the inflammatory process in obese WAT. As shown in
Fig 5A, the addition of exogenous PGE2 to fat explants resulted in a reduced expression of the
inflammatory cytokines IL-6 and MCP-1. Consistent with this finding, PGE2 significantly pre-
vented the up-regulated expression of COX-2 and IL-6 in 3T3 adipocytes exposed to LPS (Fig
5B). The anti-inflammatory actions of PGE2 were subsequently confirmed by microarray anal-
ysis of human pre-adipocytes incubated with this eicosanoid (S1 Fig).
Effects of PGE2 onWAT browning
Thereafter we investigated the effects of PGE2 on the browning of human omental WAT. Pre-
vious studies from our laboratory in an experimental model of high-fat diet-induced obesity
have demonstrated that PGE2 stimulates the differentiation of pre-adipocytes of WAT origin
into beige/brite adipocytes [16]. In the present study, the expression of the brown marker
UCP1 was found to be significantly reduced in omental WAT of obese patients (Fig 6A). The
exogenous addition of PGE2 to humanWAT explants significantly up-regulated UCP1 and
Fig 3. Targeted lipidomic analysis of COX products in adipose tissue from control and obese individuals. (A) Levels of PGE2, 15d-PGJ2, 6-keto-
PGF1α and PGF2α in adipose tissue from non-obese control individuals (n = 6) and obese patients (n = 7) were assessed by LC-ESI-MS/MS. (B) COX-2,
mPGES-1, mPGES-2 and cPGES expression in omental adipose tissue from control (n = 7) and obese (n = 11) individuals. (C) Representative Western blot
of mPGES-1 protein expression in omental adipose tissue. (D) Correlation between the expression of COX-2 and mPGES-1 in omental adipose tissue and
the body mass index (BMI). The results are expressed as mean ± SEM. *, P<0.05 and **, P<0.01 versus control.
doi:10.1371/journal.pone.0153751.g003
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PRDM16 expression (Fig 6B). To investigate which adipose tissue fraction is involved in the
PGE2 actions, we next isolated adipocytes and SVC and analyzed the relative expression of
COX-2 and mPGES-1. As shown in Fig 6C, the expression of these PGE2-generating enzymes
was mostly ascribed to the SVC fraction, which is highly populated by pre-adipocytes. Accord-
ingly, we isolated pre-adipocytes from human omental WAT and incubated these cells with
PGE2. As shown in Fig 6D, PGE2 was not able to induce a consistent induction of UCP1
and PRDM16 in human pre-adipocytes during the process of differentiation into mature
adipocytes. In contrast, PGE2 significantly increased the expression of UCP1 and PRDM16 in
adipocytes (Fig 6E), suggesting that the browning of human omental WAT could be the conse-
quence of the trans-differentiation of mature adipocytes.
Effects of PGE2 onWAT lipolysis
Finally, we explored the effects of PGE2 onWAT lipolysis. As expected, human omental WAT
showed remarkable phosphorylation of the lipolytic enzyme hormone-sensitive lipase (HSL)
Fig 4. Effects of PGE2 on adipose tissue remodeling. (A)mRNA expression for COL1α1, TIMP1, COL1α2 and TGF-β in obese fat pads incubated with
vehicle (Veh) or PGE2 (1 μM). (B)mRNA expression for COL1α1, TIMP1, COL1α2, TGF-β and αSMA in differentiated 3T3-L1 adipocytes growing in the
presence of Veh, (0.19% DMSO) or TGF-β (10 ng/ml). (C)mRNA expression for COL1α1, TIMP1, COL1α2, TGF-β and αSMA in 3T3-L1 adipocytes growing
in the presence of TGF-β (10 ng/ml) and incubated with vehicle (Veh) or PGE2 (0.1 μM). The results are expressed as mean ± SEM. *, P<0.05 and **,
P<0.01 versus Veh.
doi:10.1371/journal.pone.0153751.g004
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(Fig 6F). Incubation of human adipocytes with the lipolytic compound isoproterenol resulted
in enhanced adipocyte lipolysis, an effect that was significantly decreased by PGE2 (Fig 6G).
Discussion
The results of the current investigation demonstrate the presence of increased levels of PGE2 in
the adipose tissue of obese subjects as compared to lean individuals. The increased levels of this
prostanoid were not related to an overexpression of mPGES-1, the main PGE synthase in adi-
pose tissue cells [21], but rather with COX-2, which expression was found remarkably up-regu-
lated in obese adipose tissue. In addition, the current study provides evidence that exogenous
addition of PGE2 exerts multiple effects on the homeostatic control of obese adipose tissue.
Specifically, our results identified PGE2 as a potent regulator of the pathologic processes lead-
ing to uncontrolled inflammation and fibrosis and impaired adaptive thermogenesis and lipol-
ysis in white adipose tissue during obese conditions.
An interesting finding of our study was the observation that PGE2 had the ability to regulate
WAT fibrosis. Fibrosis is a hallmark of metabolically dysfunctional WAT in which adipocytes
are surrounded by a network of extracellular matrix proteins [10,12]. The exaggerated accumu-
lation of extracellular matrix reduces the plasticity of adipose tissue leading to adipocyte
Fig 5. Anti-inflammatory effects of PGE2 on adipose tissue. (A)mRNA expression for COX-2, IL-6 and MCP-1 in human obese fat pads incubated with
vehicle (Veh) or PGE2 (1 μM). (B) COX-2, IL-6 and MCP-1 expression in differentiated 3T3-L1 adipocytes growing in the presence of LPS (100 ng/ml) and
incubated with increasing concentrations of PGE2 (0, 1 and 5 μM). The results are expressed as mean ± SEM. #, P<0.05, ##, P<0.01 and ###, P<0.001 for
LPS versus untreated cells. *, P<0.05 and **, P<0.01 versus Veh or LPS.
doi:10.1371/journal.pone.0153751.g005
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Fig 6. Effects of PGE2 on beige/brite differentiation. (A) Adipose tissue expression of UCP1 in adipose tissue from non-obese control individuals (n = 10)
and obese patients (n = 11). (B) Expression of UCP1 and PRDM16 in obese fat pads incubated with vehicle (Veh, 0.19% DMSO) or PGE2 (1 μM) for 24
hours. (C) Representative photomicrographs of stromal vascular cell (SVC) and adipocyte cultures isolated from adipose tissue of obese patients (x200
magnification; scale bars; 200 μm). Right panel: Expression of COX-2 and mPGES-1 in SVC and adipocytes from obese adipose tissue.D) Expression of
UCP1 and PRDM16 in differentiated pre-adipocytes isolated from obese patients growing in the presence of Veh (0.19%DMSO) or PGE2 (1 μM). (E)
Expression of UCP1 and PRDM16 in adipocytes isolated from obese adipose tissue and incubated with Veh (0.19%DMSO) or PGE2 (1 μM) for 3 h. (F)
Representative western blot of phosphorylated HSL (pHSL) protein expression in adipose tissue from non-obese control individuals (CT) (n = 7) and obese
patients (Ob) (n = 8). (G)Glycerol levels released by adipocytes incubated with vehicle (V) (0.19%DMSO) or isoproterenol (1 μM) in the presence of V or
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dysfunction [12]. Indeed, total and pericellular fibrosis as determined by a combination of
techniques including Sirius Red and Masson’s trichrome staining as well as visualization of col-
lagen fibers (red, type I collagen; green, type III collagen) under polarized light microscopy,
clearly indicated the presence of increased fibrosis in omental WAT from obese individuals. In
this tissue, PGE2 down-regulated the expression of fibrosis-inducing genes in human fat
explants from obese individuals as well as the fibrogenic response of differentiated adipocytes
to the fibrogenic actions of TGF-β, a cytokine that plays a pivotal role in fibrosis by regulating
matrix synthesis and deposition [22]. These findings are novel because, as far as we know, this
is the first study assessing the effects of PGE2 on WAT fibrosis. Our findings are consistent
with those previously reported for PGE2 in other tissues and organs. In this regard, PGE2 has
been reported to exert antifibrotic effects in the lung by inhibiting multiple fibroblast functions
as well as fibroblast survival [23]. Similar findings have been reported in the liver where
PGE2 inhibits TGF-β-mediated induction of collagenα1(I) and delays the mitogenic effect of
PDGF-BB in hepatic stellate cells [23,24].
A salient feature of our study was the observation that PGE2 exerts anti-inflammatory
actions in obese adipose tissue. Indeed, PGE2 inhibited the expression of inflammatory genes
in obese fat explants and reduced the inflammatory response of differentiated adipocytes chal-
lenged with the bacterial product LPS. While contributing to the initiation of inflammation by
promoting vasodilation, pain and fever, PGE2 has been demonstrated to suppress the activa-
tion of immune cells, mainly macrophages [25–28]. This eicosanoid appears to limit nonspe-
cific inflammation as part of immune suppression associated with chronic inflammation. In
particular, PGE2 mediates suppression of type 1 immunity especially at later stages of immune
responses [25,26]. The ability of PGE2 to promote tissue host self-preservation has been docu-
mented to be mediated by the increase in the levels of the intracellular second messenger
cAMP [28]. Alternatively, PGE2 has the ability to switch eicosanoid biosynthesis from predom-
inantly inflammatory mediators (such as LTB4) to pro-resolution factors (such as LXA4) able
to stop unremitting inflammation [28]. Although it has recently been suggested that adipocyte
inflammation is essential for healthy WAT expansion and remodeling [29], a wealth of evi-
dence indicate adipose tissue inflammation has a fundamental negative impact on metabolism
leading to comorbidities associated with obesity, including insulin resistance and non-alcoholic
fatty liver disease [11]. Therefore, our observation that PGE2 counter-regulates inflammation
in obese WAT highlights the potential compensatory actions of this eicosanoid in inflamed
WAT.
Our study also provides evidence that PGE2 modulates adaptive thermogenesis in omental
WAT from obese individuals. In this regard, exogenous addition of PGE2 induced the expres-
sion of UCP1, a gene that plays a pivotal role in the browning of omental WAT. Previous work
from our laboratory has demonstrated that exposure of pre-adipocytes of WAT origin to PGE2
results in a browning effect during the adipocyte differentiation process [16]. This seminal dis-
covery was performed in a murine model of obesity and in the current study we translated this
finding to humans, demonstrating that PGE2 increases brown markers in omental WAT from
obese patients. However, there is an important difference between the human and murine
results. In humans, PGE2 induced UCP1 expression in mature adipocytes but not in pre-adipo-
cytes, whereas in mice, the browning was exclusively ascribed to preadipocytes. Together, these
data suggest that the browning of human obese WAT can implicate the trans-differentiation of
mature white adipocytes into beige/brite cells. Understanding the mechanisms underlying
PGE2 (1 μM) for 1.5 h. The results are expressed as mean ± SEM. *, P<0.05 versus control or Veh; a, P<0.05 and b P<0.01 versus SVC. #, P<0.05 versus
isoproterenol-treated adipocytes.
doi:10.1371/journal.pone.0153751.g006
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adipocyte transdifferentiation is likely to open new avenues for the design of novel strategies
for the treatment of obesity and associated metabolic disorders [30].
Finally, PGE2 exerted anti-lipolytic actions on omental WAT, as estimated by a reduction in
the activity of HSL, the most important lipolytic enzyme in WAT. This finding confirms the
anti-lipolytic effects of PGE2 in humans originally reported in rat WAT [31]. Since augmented
HSL activity in obese omental WAT results in increased release of non-essential fatty acids
into the circulation and impaired β-cell function, insulin resistance and fatty liver disease [32],
PGE2 can also be postulated as a key regulator of systemic metabolism.
In summary, the present study demonstrates that PGE2 exerts pleiotropic effects on human
obese WAT, counter-regulating the unbalanced activity of the inflammation-fibrosis axis,
adaptive thermogenesis and lipolysis. The current investigation was performed in omental
WAT samples from patients with obesity undergoing laparoscopic bariatric surgery, and there-
fore our findings are relevant in terms of human obesity.
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